ICVX - Icosavax - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

59.28M

Cash

246.9M

Avg Qtr Burn

-17.47M

Short % of Float

5.00%

Insider Ownership

3.72%

Institutional Own.

71.74%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
IVX-A12 (RSV+hMPV) Details Respiratory syncytial virus, Human metapneumovirus, Vaccine	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IVX-121 Details Respiratory syncytial virus	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IVX-411 Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.